Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria. (2018)
Attributed to:
mTOR control of effector CD4+ T cell activation during malaria infection
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1801737115
PubMed Identifier: 29954866
Publication URI: http://europepmc.org/abstract/MED/29954866
Type: Journal Article/Review
Volume: 115
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 28
ISSN: 0027-8424